Sexually Transmitted Diseases (STD) Diagnostics Market: Rising Demand for Accurate and Rapid Testing
The Sexually Transmitted Diseases (STD) Diagnostics Market is a critical segment of the global healthcare and diagnostics industry, driven by the increasing prevalence of sexually transmitted infections (STIs) and the growing need for early detection and treatment. STDs, including chlamydia, gonorrhea, syphilis, human immunodeficiency virus (HIV), and human papillomavirus (HPV), continue to pose significant public health challenges worldwide. The Sexually Transmitted Diseases (STD) Diagnostics Market was valued at approximately USD 7.1 billion in 2023 and is projected to reach around USD 15.9 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period. This growth is driven by the rising prevalence of sexually transmitted infections Request the Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1207 The increasing adoption of point-of-care testing, molecular diagnostics, and rapid testing kits is...